I. Logeart

发表

Validation of a short form of the Western Ontario and McMaster Universities Osteoarthritis Index function subscale in hip and knee osteoarthritis.

M. Dougados, G. Baron, F. Tubach, 2007, Arthritis and rheumatism.

Retention rates of adalimumab, etanercept and infliximab as first and second-line biotherapy in patients with rheumatoid arthritis in daily practice.

M. Dougados, I. Logeart, X. Mariette, 2014, Joint, bone, spine : revue du rhumatisme.

The Influence of the Definition of Patient Global Assessment in Assessment of Disease Activity According to the Disease Activity Score (DAS28) in Rheumatoid Arthritis

M. Dougados, I. Logeart, P. Hilliquin, 2011, The Journal of Rheumatology.

Naturalistic survey on nonsteroidal antiinflammatory treatment in patients with musculoskeletal pain.

I. Logeart, P. Goupille, B. Combe, 2003, Joint, bone, spine : revue du rhumatisme.

Nonsteroidal antiinflammatory drug intake according to the Assessment of SpondyloArthritis International Society Score in clinical trials evaluating tumor necrosis factor blockers: Example of etanercept in advanced ankylosing spondylitis

M. Dougados, I. Logeart, B. Combe, 2012, Arthritis care & research.

Factors determining a DMARD initiation in early inflammatory arthritis patients. The ESPOIR cohort study.

F. Guillemin, D. M. van der Heijde, I. Logeart, 2009, Clinical and experimental rheumatology.

Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state

C. Bombardier, M. Dougados, D. Felson, 2004, Annals of the rheumatic diseases.

Short-Term Efficacy of Rofecoxib and Diclofenac in Acute Shoulder Pain: A Placebo-Controlled Randomized Trial

M. Dougados, P. Ravaud, I. Logeart, 2007, PLoS clinical trials.

Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE)

M. Dougados, I. Logeart, B. Combe, 2011, Annals of the rheumatic diseases.

Feeling good rather than feeling better matters more to patients.

M. Dougados, G. Baron, F. Tubach, 2006, Arthritis and rheumatism.

Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement

C. Bombardier, M. Dougados, D. Felson, 2004, Annals of the rheumatic diseases.

Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study

M. Dougados, I. Logeart, F. Berenbaum, 2014, Arthritis Research & Therapy.

A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial

M. Dougados, D. M. van der Heijde, I. Logeart, 2010, Annals of the rheumatic diseases.

Continuous efficacy of etanercept in severe and advanced ankylosing spondylitis: results from a 12-week open-label extension of the SPINE study.

M. Dougados, I. Logeart, B. Combe, 2012, Rheumatology.

Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritis

M. Dougados, D. M. van der Heijde, I. Logeart, 2017, Annals of the rheumatic diseases.

Evaluation of whether extremely high enthesitis or Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) scores suggest fibromyalgia and confound the anti-TNF response in early non-radiographic axial spondyloarthritis.

M. Dougados, I. Logeart, H. Jones, 2017, Clinical and experimental rheumatology.

Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial

M. Dougados, Mahboob Rahman, I. Logeart, 2014, Arthritis & rheumatology.

The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients.

M. Dougados, D. M. van der Heijde, I. Logeart, 2011, Joint, bone, spine : revue du rhumatisme.

The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis

C. Bombardier, M. Dougados, D. Felson, 2016, The Journal of Rheumatology.

Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study

M. Dougados, I. Logeart, S. Kotak, 2015, Annals of the rheumatic diseases.

Effects of Long‐Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104‐Week Results From a Randomized, Placebo‐Controlled Study

M. Dougados, D. M. van der Heijde, I. Logeart, 2017, Arthritis care & research.

Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study

C. Bombardier, M. Dougados, D. Felson, 2012, Arthritis care & research.

Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis

I. Logeart, J. Daurès, B. Combe, 2011, Annals of the rheumatic diseases.

Validation of a numerical rating scale to assess functional impairment in hip and knee osteoarthritis: comparison with the WOMAC function scale

M. Dougados, I. Logeart, L. Gossec, 2010, Annals of the rheumatic diseases.

Individualising the Western Ontario and McMaster Universities osteoarthritis index (WOMAC) function subscale: incorporating patient priorities for improvement to measure functional impairment in hip or knee osteoarthritis

M. Dougados, G. Baron, F. Tubach, 2007, Annals of the rheumatic diseases.

Clinical and Ultrasound‐Based Composite Disease Activity Indices in Rheumatoid Arthritis: Results From a Multicenter, Randomized Study

M. Dougados, I. Logeart, W. Grassi, 2013, Arthritis care & research.

The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients.

M. Dougados, F. Guillemin, P. Ravaud, 2007, Joint, bone, spine : revue du rhumatisme.

[Arteriovenous malformations: a study of 200 cases].

I. Logeart, J. Guichard, D. Reizine, 2000, Annales de dermatologie et de venereologie.

SAT0473 Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the rheumatoid arthritis impact of disease (RAID)

M. Dougados, D. M. van der Heijde, I. Logeart, 2013 .

Development of Multinational Definitions of Minimal Clinically Important Improvement and Patient Acceptable Symptomatic State in Osteoarthritis

C. Bombardier, M. Dougados, M. Hochberg, 2015, Arthritis care & research.

Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort

M. Dougados, I. Logeart, J. Daurès, 2014, Annals of the rheumatic diseases.

Five-year Favorable Outcome of Patients with Early Rheumatoid Arthritis in the 2000s: Data from the ESPOIR Cohort

M. Dougados, F. Guillemin, P. Ravaud, 2013, The Journal of Rheumatology.

SAT0405 No Radiological Sacroiliac Joint Progression after 2 Years of Etanercept Treatment in Non-Radiographic Axial Spondyloarthritis: Data from The Embark Study

M. Dougados, D. M. van der Heijde, I. Logeart, 2016 .

Discriminant Capacity of Clinical Efficacy and Nonsteroidal Antiinflammatory Drug-sparing Endpoints, Alone or in Combination, in Axial Spondyloarthritis

M. Dougados, D. M. van der Heijde, I. Logeart, 2015, Journal of Rheumatology.

Using patients’ and rheumatologists’ opinions to specify a short form of the WOMAC function subscale

M. Dougados, N. Bellamy, G. Baron, 2004, Annals of the rheumatic diseases.

Management of osteoarthritis (OA) with an unsupervised home based exercise programme and/or patient administered assessment tools. A cluster randomised controlled trial with a 2×2 factorial design

B Bannwarth, B Giraudeau, M. Dougados, 2004, Annals of the rheumatic diseases.

[Prescribing patterns of rofecoxib in the primary care setting: results of a French survey].

I. Logeart, B. Bannwarth, G. Vergult, 2004, La Revue de medecine interne.

Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID)

M. Dougados, D. M. van der Heijde, I. Logeart, 2012, Arthritis Research & Therapy.

Metrologic properties of ultrasound versus clinical evaluation of synovitis in rheumatoid arthritis: results of a multicenter, randomized study.

M. Dougados, D. M. van der Heijde, I. Logeart, 2012, Arthritis and rheumatism.

Predictive factors of total hip replacement due to primary osteoarthritis: a prospective 2 year study of 505 patients

M. Dougados, G. Baron, F. Tubach, 2005, Annals of the rheumatic diseases.

When to Adjust Therapy in Patients with Rheumatoid Arthritis After Initiation of Etanercept plus Methotrexate or Methotrexate Alone: Findings from a Randomized Study (COMET)

M. Dougados, D. M. van der Heijde, I. Logeart, 2014, Journal of Rheumatology.

Onset of action of etanercept in rheumatoid arthritis based on patient-reported outcomes.

M. Dougados, I. Logeart, P. Hilliquin, 2012, Clinical and experimental rheumatology.

Effi cacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis : results of a randomised double-blind placebo-controlled study ( SPINE )

M. Dougados, I. Logeart, B. Combe, 2022 .

Extended Report

M. Dougados, H. Genant, I. Logeart, 2022 .

Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state

D. Felson, I. Logeart, D. Heijde, 2004, Annals of the rheumatic diseases.

The Influence of the Definition of Patient Global Assessment in Assessment of Disease Activity According to the Disease Activity Score (DAS28) in Rheumatoid Arthritis

I. Logeart, M. Dougados, Yves Brault, 2011, The Journal of Rheumatology.

Discriminant Capacity of Clinical Efficacy and Nonsteroidal Antiinflammatory Drug-sparing Endpoints, Alone or in Combination, in Axial Spondyloarthritis

M. Dougados, D. M. van der Heijde, I. Logeart, 2015, The Journal of Rheumatology.